TCIM
BOLD
TIAA CREF Investment Management’s Audentes Therapeutics, Inc BOLD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $3.64M | Buy |
93,275
+22,026
| +31% | +$860K | ﹤0.01% | 1646 |
|
|
2018
Q4 | $1.52M | Buy |
71,249
+3,470
| +5% | +$74K | ﹤0.01% | 2110 |
|
|
2018
Q3 | $2.68M | Sell |
67,779
-5,314
| -7% | -$210K | ﹤0.01% | 1964 |
|
|
2018
Q2 | $2.79M | Buy |
73,093
+26,123
| +56% | +$998K | ﹤0.01% | 1990 |
|
|
2018
Q1 | $1.41M | Sell |
46,970
-8,501
| -15% | -$255K | ﹤0.01% | 2272 |
|
|
2017
Q4 | $1.73M | Sell |
55,471
-2,636
| -5% | -$82.4K | ﹤0.01% | 2213 |
|
|
2017
Q3 | $1.63M | Sell |
58,107
-6,390
| -10% | -$179K | ﹤0.01% | 2282 |
|
|
2017
Q2 | $1.23M | Buy |
64,497
+52,965
| +459% | +$1.01M | ﹤0.01% | 2447 |
|
|
2017
Q1 | $197K | Sell |
11,532
-334
| -3% | -$5.71K | ﹤0.01% | 2998 |
|
|
2016
Q4 | $217K | Buy |
+11,866
| New | +$217K | ﹤0.01% | 3032 |
|